The Neurovascular Devices Market is becoming increasingly important in modern stroke and cerebrovascular disease management. Growing stroke incidence, an aging population, and the shift toward catheter-based interventions are supporting demand for advanced neurovascular technologies. According to Market Research Future, the market is expected to grow from USD 5.56 billion in 2026 to USD 10.48 billion by 2035, representing a CAGR of 8.22%.

Ischemic stroke represents a major application area for neurovascular devices. The segment accounted for approximately 53.5% of the market in 2025, reflecting the significant global burden of ischemic stroke and the increasing use of mechanical thrombectomy. Improved imaging-based patient selection is also helping physicians identify candidates for endovascular procedures more effectively.

Aneurysm treatment is another important area of opportunity. Flow diverters, embolization coils, microcatheters, and other specialized technologies are enabling physicians to treat cerebral aneurysms through less invasive approaches. The cerebral aneurysm segment is projected to grow at an 8.86% CAGR through 2035, supported by increasing adoption of flow-diverter technologies and improvements in aneurysm diagnosis.

The market is also benefiting from advancements in artificial intelligence and robotic-assisted intervention. AI-based stroke triage can support faster clinical decision-making, while robotic navigation systems may improve catheter control and procedural consistency. These innovations could expand access to specialized neuro-interventional treatment in hospitals that face shortages of experienced specialists.

With continued investment in stroke infrastructure and next-generation devices, the Neurovascular Devices Market is positioned for sustained growth. Manufacturers that combine advanced hardware with digital guidance, analytics, and minimally invasive capabilities are likely to find significant opportunities in both developed and emerging healthcare markets.